MCBR has a provision to facilitate Biopharma companies with GMP lab/infra-structure to start MAHE-Pvt. Partnership research unit at MAHE at a very nominal usage fee or potential option to outsource translational research projects to MCBR.

MCBR is at Advanced stage of collaborative discussions with

•       Stempeutics Research

•       Curio Biotech, Switzerland

•       Esco Aster, Singapore

•       Cipla Ltd

We welcome more collaborative initiative to the companies for developing novel Biotherapeutics products.